Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2013
10/22/2013US8563806 Nematode inducible promotors and methods of use
10/22/2013US8563805 Genetically modified reduced-browning fruit-producing plant and produced fruit thereof, and method of obtaining such
10/22/2013US8563804 Amphidiploid aquatic animal and method of breeding the same
10/22/2013US8563803 Method of making protein in an egg of a transgenic chicken
10/22/2013US8563709 Method for inhibiting function of micro-RNA
10/22/2013US8563708 Methods and compositions involving miRNA and miRNA inhibitor molecules
10/22/2013US8563704 Peptide aptamer for neutralizing the binding of platelet antigen specific antibodies and diagnostic and therapeutic applications containing the same
10/22/2013US8563687 Synthetic genes for plant gums and other hydroxyproline rich glycoproteins
10/22/2013US8563684 Tumor antigen protein SART-3 and tumor antigen peptides thereof
10/22/2013US8563529 RNAi therapeutic for treatment of hepatitis C infection
10/22/2013US8563528 Antisense oligomers targeting PCSK9
10/22/2013US8563521 Biological active proteins having increased in vivo and/or in vitro stability
10/22/2013US8563519 Methods of activating or inhibiting G protein coupled receptors (GPCRs)
10/22/2013US8563507 Method of treating a disease or condition characterized by aberrant epithelial cell proliferation
10/22/2013US8563503 Antibiotic, its nucleotide sequence, methods of construction and uses thereof
10/22/2013US8563500 Methods and compounds for treating diseases caused by reactive oxygen species
10/22/2013US8563314 Methods and compositions for modulating PD1
10/22/2013US8563313 Macrophage cell-lines for propagation of porcine reproductive and respiratory syndrome virus
10/22/2013US8563311 Methods of culturing cells in a medium comprising transforming growth factor beta 1 and basic fibroblast growth factor
10/22/2013US8563309 Primitive organ-like structure comprising keratinocytes and hair papilla cells
10/22/2013US8563302 Optimized high yield synthetic plasmids
10/22/2013US8563291 Method of constructing recombinant proteoliposome for diagnostic use
10/22/2013US8563290 Pectate lyase variants
10/22/2013US8563286 Polypeptides having lipase activity and polynucleotides encoding same
10/22/2013US8563285 Isoforms of eIF-5A: senescence-induced eIF5A; wounding-induced eIF-5A; growth eIF-5A; and DHS
10/22/2013US8563271 Antibodies specific for sclerostin and methods for increasing bone mineralization
10/22/2013US8563269 Modified antibody compositions, methods of making and using thereof
10/22/2013US8563239 Solid support having electrostatic layer and use thereof
10/22/2013US8563236 Mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance
10/22/2013US8563007 Immunogenic compositions for the prevention and treatment of meningococcal disease
10/22/2013US8563006 Immunogenic compositions for the prevention and treatment of meningococcal disease
10/22/2013US8562994 Human-murine chimeric antibodies against respiratory syncytial virus
10/22/2013US8562992 Immunoglobulin variants and uses thereof
10/22/2013US8562985 Antibodies to c-Met
10/22/2013US8562977 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
10/22/2013US8562970 Modified CEA/B7 vector
10/22/2013CA2707726C Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease
10/22/2013CA2673395C Human endogenous retrovirus with foamy-like properties and uses thereof
10/22/2013CA2599381C Corn event 3272 and methods for detection thereof
10/22/2013CA2598414C Metabolically engineered cells for the production of resveratrol or an oligomeric or glycosidically-bound derivative thereof
10/22/2013CA2580981C Stabilized human igg4 antibodies
10/22/2013CA2580719C Small molecules that replace or agonize p53 function
10/22/2013CA2575433C Bacteria detection device, bacteria detection method and bacteria detection kit
10/22/2013CA2571369C Antifungal polypeptides
10/22/2013CA2566199C Delivery of as-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes
10/22/2013CA2554089C Albumin fusion proteins
10/22/2013CA2550642C Oligonucleotide compound and method for treating nidovirus infections
10/22/2013CA2526720C Recombinant carrier molecule for expression, delivery and purification of target polypeptides
10/22/2013CA2525698C A nucleic acid construct containing a nucleic acid derived from the genome of hepatitis c virus (hcv) of genotype 2a, and a cell having such nucleic acid construct introduced therein
10/22/2013CA2524569C A method of regulating gene expression
10/22/2013CA2505895C Expression profiling based on histocultures
10/22/2013CA2474344C Expansion of renewable stem cell populations
10/22/2013CA2464874C Intraoperative lymph node assay
10/22/2013CA2412626C Il-17 molecules and uses thereof
10/22/2013CA2405035C Improved method for the production of bacterial toxins
10/22/2013CA2367750C Tribonectins
10/17/2013WO2013155481A1 Improved cellodextrin transport and mixed sugar fermentation
10/17/2013WO2013155447A1 Tiki inhibitors
10/17/2013WO2013155406A1 Contragestion and treating inflammation by modulating sodium channel activity in the epithelium
10/17/2013WO2013155346A1 Diagnostic tools for response to 6-thiopurine therapy
10/17/2013WO2013155330A1 Compositions and methods for characterizing and treating muscular dystrophy
10/17/2013WO2013155273A1 Triglyceride production in e. coli
10/17/2013WO2013155204A2 Compositions and methods for inhibiting expression of the alas1 gene
10/17/2013WO2013155056A1 Compositions and methods for quantifying a nucleic acid sequence in a sample
10/17/2013WO2013155001A1 Mutation of the ear motif of class ii hd-zip polypeptides
10/17/2013WO2013154766A1 Microrna control of ldl receptor pathway
10/17/2013WO2013154760A1 Chimeric antigen receptors targeting b-cell maturation antigen
10/17/2013WO2013154735A1 Rna aptamers for therapeutic and diagnostic delivery to pancreatic cancer cells
10/17/2013WO2013154731A1 Protein scaffolds for selective enrichment of metal ions
10/17/2013WO2013154730A1 Enhancing protein stability in transgenic plants
10/17/2013WO2013154503A1 Methods for bladder cancer therapy using baculoviral vectors
10/17/2013WO2013154312A1 Method for producing a toxic protein by using laci protein mutant
10/17/2013WO2013154304A2 Method for preparing a nucleic acid with high precision used in detecting a nucleic acid with a nucleic acid polymerase
10/17/2013WO2013154233A1 Sycmv-derived recombinant virus vector, and use thereof
10/17/2013WO2013154206A1 Anti-fgfr2 antibody
10/17/2013WO2013154192A1 Medicinal composition for treating infarction
10/17/2013WO2013154182A1 Method for producing amino acid
10/17/2013WO2013154138A1 Method for detecting target nucleic acid using molecular beacon-type probe
10/17/2013WO2013154128A1 Novel arteriosclerosis treatment drug composition and method for screening arteriosclerosis treatment drugs
10/17/2013WO2013154109A1 Novel 1-substituted indazole derivative
10/17/2013WO2013153911A1 Nucleic acid quantification method, detection probe, detection probe set, and nucleic acid detection method
10/17/2013WO2013153553A2 Compositions for controlling varroa mites in bees
10/17/2013WO2013153404A1 Production of omega-3 long chain polyunsaturated fatty acids
10/17/2013WO2013153391A1 Polypeptide useful in adoptive cell therapy
10/17/2013WO2013153361A1 Gene expresssion from mitotically stable episomes
10/17/2013WO2013153237A1 Qtl responsible for tomato fruit firmness
10/17/2013WO2013153159A1 Antibiotic sensitive bacillus strains having antimicrobial effect against e. coli and clostridium perfringens and having high sporulation capacity
10/17/2013WO2013153138A1 Matrix metalloproteinase 9 (mmp-9) aptamer and uses thereof
10/17/2013WO2013153082A1 Methods for the treatment of nonalcoholic steatohepatitis
10/17/2013WO2013152917A1 Fungal resistant plants expressing ocp3
10/17/2013WO2013152904A1 Method for digesting biological cells
10/17/2013WO2013152624A1 Synthetic glyphosate-resistant gene and use thereof
10/17/2013WO2013152456A1 Maize authentication detection and molecular breeding snp chip - maizesnp3072 and detection method thereof
10/17/2013WO2013152408A2 Compositions and methods for modifying the expression of genes of interest
10/17/2013WO2013116698A3 High throughput screen for biologically active polypeptides
10/17/2013WO2013105800A3 Microorganisms of escherichia coli having enhanced l-tryptophan production and method for producing l-tryptophan using same
10/17/2013WO2013102147A3 Genetic switches for butanol production
10/17/2013WO2013091612A3 Novel plant-derived cis-regulatory elements for the development of pathogen-responsive chimeric promotors
10/17/2013WO2013090814A3 p-Coumaroyl-CoA:Monolignol Transferase
10/17/2013WO2013081571A3 Isolated lyssavirus nucleic acid and protein sequences
1 ... 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 ... 4023